Solugen and Kraken Kinetics announced Odin Energetics, a $115 million joint venture to produce HMX and RDX explosives for the Pentagon's Drone Dominance program. The venture targets production next year to address a one-to-two-year wait at Holston Army Ammunition Plant, the sole U.S. producer.
What's happening
- Odin Energetics, backed by Solugen and Kraken Kinetics with $115 million capital, will produce HMX and RDX explosives in modular shipping-container factories deployable in six months.
- The Pentagon committed to buying 60,000 attack drones under Drone Dominance, with virtually all designed to carry explosives.
- Holston Army Ammunition Plant in Tennessee remains the only U.S. HMX and RDX producer but operates at roughly 3 percent of its 1944 peak capacity with a one-to-two-year customer queue.
- Odin says it can produce close to one-tenth of Holston's roughly 11 million pounds annual output and demonstrated a formulation claimed to be 30 percent more powerful than current military explosives.
Why it matters
- A 60,000-drone order depends on a single aging plant with limited capacity and extended lead times, creating program risk and potential delays in fielding Drone Dominance by the 2027 deadline.
- The Army's $1 billion modernization of Holston was due in 2025 and now targets 2029 or later, widening the supply gap during peak drone production.
- Multiple U.S. explosives producers were closed in the 1990s and European supplies are committed to Ukraine rearmament, leaving few alternatives to domestic production surge.
- Distributed, rapid-deployment factories at military bases reduce dependency on a single aging facility and potentially accelerate explosives supply to field operations.
Going deeper
- Defense Secretary Hegseth's July 2025 directive classified small drones as consumables, shifting procurement from expensive weapons used rarely to large numbers of single-use platforms.
- The Army announced a $903 million research facility in Kentucky in March and established a Pentagon office for energetics production to raise HMX and RDX output before 2031.
- Solugen ships starting chemicals by ordinary truck and produces explosive only at Odin's site, positioning the venture to address industry safety concerns tied to accidents and facility shutdowns.
Financial impact
- Odin is a private joint venture structured as a strategic partnership, with $115 million capital deployed to build and deploy modular manufacturing capacity; timing of revenue recognition depends on contract awards from Army or Pentagon Office of Strategic Capital.
- Kraken Kinetics, a warhead builder and Odin co-founder, stands to recognize revenue from explosive supply and any warhead integration work tied to Drone Dominance; contract terms and timing not disclosed.
- The Army and Pentagon Office of Strategic Capital are in discussions with Odin about supplying advanced explosives; formalization into contracts will determine cash flow timing and runway, likely in fiscal 2027 or later.
The intrigue
- Kraken Kinetics was not named as a lethality supplier to any Gauntlet II drone entrant in Phase 3 scoring, yet the firm is now central to Odin's explosive supply, suggesting either late-stage supplier alignment or a separate warhead integration track.
- Phase 3 allocated $450 million across drone producers, running $150 million above listed airframe prices, indicating payloads may command significant budget but actual explosives cost and allocation remain opaque.
The fine print
- Odin promises small quantities next year but remains at the plan stage; no contract with the Army or Pentagon has been announced, and Drone Dominance Phase 3 drones may reach fielding before explosive supply is certified and scaled.
- Odin's claimed 30 percent power advantage over current military explosives is the company's own figure and requires Army validation before integration into production warheads.
- Solugen's largest investor is Peter Thiel's Founders Fund; ownership stakes in the joint venture and rights to technology or supply agreements are not disclosed.




